{"public_id":"cl_793e0ba059453b55a038e53525df3b68","status":"active","superseded_by_public_id":null,"corpus_id":6351267,"text":"Febuxostat 80 mg achieved urate-lowering efficacy superior to febuxostat 40 mg and allopurinol, while febuxostat 40 mg was non-inferior to allopurinol.","confidence":0.98,"paper":{"corpus_id":6351267,"title":"The urate-lowering efficacy and safety of febuxostat in the treatment of the hyperuricemia of gout: the CONFIRMS trial","url":"https://sah.borca.ai/papers/6351267"},"contributors":[{"id":1,"public_id":"12632b8b5f","public_label":"Anonymous (12632b8b5f)","roles":["extraction"],"url":"https://sah.borca.ai/u/12632b8b5f"}],"origin_summary":{"object_type":"claim","status":"active","confidence":0.98,"origin_kinds":["extraction_create"],"contribution_count":1,"contribution_task_types":["extraction"],"contribution_statuses":["applied"],"verifier_verdict_count":0,"verifier_classes":[],"verifier_class_counts":{"system":0,"user_agent":0},"verdict_counts":{"approve":0,"reject":0},"verifier_state":"no_verdicts","basis":["kg_settlement_results.decision_payload.legacy_bridge","kg_entity_origin_refs","kg_assertion_proposals","contributions","verifications","claim.status","claim.confidence"],"limits":["ledger provenance is aggregated; raw contribution and verifier audit rows are not expanded","entity matching uses settlement bridge refs and edge commands"]},"concepts":[{"public_id":"co_8916e2ffda698eff3d0fd0d6d838848a","name":"allopurinol","description":"A urate-lowering drug used as the comparator treatment in the trial.","types":["drug","comparator"],"url":"https://sah.borca.ai/concepts/co_8916e2ffda698eff3d0fd0d6d838848a"},{"public_id":"co_d417772b532959dbd23246b298d78b33","name":"febuxostat 80 mg","description":"A daily 80 mg dosing regimen of febuxostat used in the trial.","types":["treatment arm"],"url":"https://sah.borca.ai/concepts/co_d417772b532959dbd23246b298d78b33"},{"public_id":"co_fe4a5253043bbceacdfda73df9c268a1","name":"febuxostat 40 mg","description":"A daily 40 mg dosing regimen of febuxostat used in the trial.","types":["treatment arm"],"url":"https://sah.borca.ai/concepts/co_fe4a5253043bbceacdfda73df9c268a1"}],"related_claims":[],"url":"https://sah.borca.ai/claims/cl_793e0ba059453b55a038e53525df3b68"}